A World Pancreatic Cancer Day meeting took place at the IRCCS Fondazione G. Pascale in Naples on 19 November 2026, bringing together specialists, researchers, patients and associations to discuss new treatments, according to ANSA.
The central therapeutic issue was daraxonrasib, a targeted treatment directed at the Ras protein. According to ANSA, Ras is present in more than 90% of pancreatic tumors.
In the RASolute 302 study, median survival for patients with metastatic disease previously treated with chemotherapy rose from 6.7 to 13.2 months. That result applies to patients with metastatic pancreatic adenocarcinoma previously treated with chemotherapy and should not be generalized to every pancreatic-cancer patient.
European authorization and a positive opinion from the European Medicines Agency committee had been obtained, but Italy still needed to complete price and reimbursement procedures. The final Italian price, reimbursement status, eligibility rules and national availability date for daraxonrasib were not established.
The Italian Medicines Agency, AIFA, said it had started a progressive rolling review of daraxonrasib following the positive European opinion. The agency said the approach aims to support faster access for eligible patients while maintaining scientific assessment and equal access regardless of residence.
Experts and patient organizations at the Naples meeting warned that delays could create regional inequalities in access to innovative treatment. The sources describe concern about territorial inequality but do not quantify how many Italian patients are already affected.
The official event program listed sessions on KRAS research, clinical trials, new therapies and dialogue with patient associations. The wider program also covered communication, patient questions and public information about pancreatic-cancer risks and symptoms.
The Nadia Valsecchi Foundation said the Naples event brought together researchers, clinicians, patient groups and science communicators. It said a public-awareness activity was later held at Zazzu Bistrot.



